UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
March 17, 2005
ULTRALIFE BATTERIES, INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation or organization)
0-20852 16-1387013
------- ----------
(Commission File Number) (I.R.S. Employer Identification No.)
2000 Technology Parkway, Newark, New York 14513
-----------------------------------------------
(Address of principal executive offices) (Zip Code)
(315) 332-7100
--------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
Ultralife Batteries, Inc. (the "Company") announced that it has been awarded a
new production contract for its BA-5390/U battery valued at approximately $7.4
million, by the U.S. Defense Department. The Company's press release is attached
as Exhibit 99.1 to this Form 8-K, and the information set forth therein is
furnished under item 7.01.
Item 9.01. Financial Statements, Pro Forma Financials and Exhibits.
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibits.
99.1 Press Release dated March 17, 2005.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRALIFE BATTERIES, INC.
Dated: March 17, 2005. By: /s/Peter F. Comerford
---------------------
Vice President of Administration
& General Counsel
INDEX TO EXHIBITS
(99) Additional Exhibits
99.1 Press Release dated March 17, 2005.
Exhibit 99.1
Ultralife Batteries, Inc. Awarded $7.4 Million Battery
Contract by U.S. Defense Department
NEWARK, N.Y.--(BUSINESS WIRE)--March 17, 2005--Ultralife
Batteries, Inc. (NASDAQ: ULBI) has been awarded a new production
contract for its BA-5390/U battery valued at approximately $7.4
million, by the U.S. Defense Department. This contract is independent
of the Next Gen II, Phase IV five-year battery contract for the
BA-5390 and four other rectangular military batteries, which the
company was awarded in December 2004. Deliveries under this $7.4
million contract are required to be completed by May 14.
"This contract once again affirms Ultralife's position as the
leading supplier of lithium/manganese dioxide batteries to the U.S.
Military," said John D. Kavazanjian, Ultralife's president and chief
executive officer. "It also illustrates the military's commitment to
adopting lithium/manganese dioxide batteries. We are gratified that
this important customer continues to have confidence in Ultralife's
ability to deliver product under tight deadlines so that it has an
ongoing supply of BA-5390 batteries ahead of battery production under
the Next Gen II, Phase IV contract."
Added Kavazanjian, "Deliveries under this contract are expected to
occur in March and April. A substantial portion of these deliveries
was anticipated in our first quarter revenue guidance. While we still
expect revenue of $18 million, due to the timing of the receipt of
this contract it is possible that some revenue may shift into the
second quarter. Our full year revenue estimate of 10% to 20% growth
over the $98.2 million we reported for 2004 remains unchanged."
The BA-5390/U is a lithium/manganese dioxide non-rechargeable
battery, and, with 50 percent more energy, is an alternative to the
lithium/sulfur dioxide BA-5590/U battery, the most widely used
military battery in the U.S. Armed Forces. The BA-5390/U is widely
used to power more than 50 military applications, such as the
AN/PRC-119 SINCGARS (Single Channel Ground and Airborne Radio System)
and the Javelin Medium Anti-Tank Missile Command Launch Unit. The
BA-5390/U provides soldiers with the latest and best battery
technology in a cost effective manner. More energy in each battery
provides longer mission time with fewer batteries for soldiers to
carry, and fewer batteries to ship and dispose of, all of which reduce
cost to the military.
About Ultralife Batteries, Inc.
Ultralife is a global provider of power solutions for diverse
applications. The company develops, manufactures and markets a wide
range of non-rechargeable and rechargeable batteries, charging systems
and accessories for use in military, industrial and consumer portable
electronic products. Through its range of standard products and
engineered solutions, Ultralife is able to provide the next generation
of power systems. Industrial, retail and government customers include
General Dynamics, Philips Medical Systems, Energizer, Kidde Safety,
Lowe's, Radio Shack and the national defense agencies of the United
States and United Kingdom, among others.
Ultralife's headquarters, principal manufacturing and research
facilities are in Newark, New York, near Rochester. Ultralife (UK)
Ltd., a second manufacturing facility, is located in Abingdon, U.K.
Both facilities are ISO-9001 certified. Detailed information about
Ultralife is available at www.ultralifebatteries.com.
This press release may contain forward-looking statements based on
current expectations that involve a number of risks and uncertainties.
The potential risks and uncertainties that could cause actual results
to differ materially include: worsening global economic conditions,
increased competitive environment and pricing pressures, disruptions
related to restructuring actions and delays. Further information on
these factors and other factors that could affect Ultralife's
financial results is included in Ultralife's Securities and Exchange
Commission (SEC) filings, including the latest Annual Report on Form
10-K.
Ultralife(R) is a registered trademark of Ultralife Batteries,
Inc.
CONTACT: Ultralife Batteries, Inc.
Julius Cirin
(315) 332-7100
jcirin@ulbi.com
or
Lippert/Heilshorn & Associates, Inc.
Media:
Chenoa Taitt, 212-201-6635
ctaitt@lhai.com
or
Investor Relations:
Jody Burfening, 212-838-3777
jburfening@lhai.com